Prucalopride for thinking and memory in schizophrenia
Treatments studied
Part of Mental health clinical trials.
This study tests whether a medication called prucalopride can help improve thinking and memory in people with schizophrenia. If you're stable on your current treatment, this trial might offer a new way to address cognitive challenges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with schizophrenia (confirmed by a clinical interview)
- Between 18 and 55 years old
- Ill for at least one year and currently stable (same medication dose for at least 3 months)
- Able to read and write English or Kannada
- Not taking certain medications like donepezil, rivastigmine, memantine, or benzodiazepines
- No serious bowel conditions like ulcerative colitis, Crohn's disease, or intestinal ulcers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment that may help with thinking and memory problems in people with schizophrenia. It is for people whose schizophrenia symptoms are stable and who are already on a steady medication.
This trial tests whether a dietary supplement called PQQ (pyrroloquinoline quinone) can improve thinking, memory, and negative symptoms (like lack of motivation) in chronic schizophrenia. It might help because PQQ has antioxidant and anti-inflammatory effects that could protect brain health.
This trial studies whether adding cromoglicate to your usual antipsychotic medicine can improve schizophrenia symptoms. It’s designed for outpatients who are already on a stable treatment and still have certain ongoing symptom scores.
This trial is testing whether it is safe to slowly reduce or stop anticholinergic medications (benztropine or trihexyphenidyl) in people with schizophrenia. It aims to see if stopping these drugs can help with thinking and memory without causing worsening movement problems.
This study tests a new medicine that may improve thinking and sleep in people with low mood. It could help if you have mild to moderate depression and are not taking other psychiatric medications.
This study tests a new combination medication (xanomeline/trospium) to see if it helps improve thinking and memory problems in people with schizophrenia. It lasts about a year, and participants continue their usual antipsychotic treatment.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.